tiprankstipranks
Acelrx Pharmaceuticals (ACRX)
NASDAQ:ACRX

Acelrx (ACRX) Stock Investors

1,890 Followers
Based on 710,644 investor portfolios analyzed by TipRanks Open your own Smart Portfolio >

Average Holdings Size

<0.1% of all portfolios hold ACRX
On average, investors allocate 2.46% of their portfolios to ACRX
The average holding size of this company in investors' portfolios.

Investor Sentiment

Currently, no data available
Please return soon. This page is being updated.
The overall sentiment of all investors covering this stock. Click on ‘Top Investors’ to focus on the best performers.

Portfolios Holding ACRX

9.8%
Last 7
Days
10.5%
Last 30
Days
Percentages indicate the change in the number of portfolios holding ACRX, out of 710,644 portfolios.
The average increase or decrease in average holding size of this stock in investor portfolios in the last 7 days or last 30 days.

ACRX Investor Activity

Investor Profile
Investor Action
Transaction Date
Portfolio Allocation
Execution Price
Follow
Increased
0.59%
$0.87
Based on the activity of 13,168 investors who made their portfolios public
The table shows changes in ACRX in the past 3 months by investors with public portfolios.
Investor activity updates every 24 hours.

ACRX Investors Also Bought

Name
Average Holding Size
Last 7D Change
Last 30D Change
Market Cap
Sector
3M Behavior
Follow
Micron
5.43%
+0.72%
+10.47%
90.95B
Technology
Snap
9.80%
-0.74%
-1.51%
27.05B
Communication Services
AMC Entertainment
5.34%
-0.96%
-1.75%
904.51M
Communication Services
Block
4.45%
-0.56%
+0.62%
40.82B
Technology
Marvell
4.86%
+1.02%
+1.05%
56.78B
Technology
Assertio Therapeutics
2.64%
-1.33%
-2.74%
85.71M
Healthcare
Boeing
6.28%
+3.95%
+6.89%
131.70B
Industrials
Merck & Company
4.26%
+0.44%
+4.06%
300.61B
Healthcare
Coherus Biosciences
2.51%
-1.28%
-0.21%
286.21M
Healthcare
ChargePoint Holdings
4.00%
-0.87%
-1.34%
794.25M
Consumer Cyclical
Based on the activity of 710,644 active portfolios
Open your Smart Portfolio

ACRX Investor Analysis

ACRX investors under 35

Under 35

0.0%
Last 30 days
Holdings Change
11.6%
of ACRX holders
are under 35
Average Segment Performance
Average P/E Ratio12.71
Beta7.13
Dividend Yield5.16%
ACRX investors between 35–55

Between 35–55

0.0%
Last 30 days
Holdings Change
58.9%
of ACRX holders
are between 35–55
Average Segment Performance
Average P/E Ratio8.18
Beta11.06
Dividend Yield5.25%
ACRX investors over 55

Over 55

0.0%
Last 30 days
Holdings Change
29.5%
of ACRX holders
are over 55
Average Segment Performance
Average P/E Ratio6.38
Beta5.82
Dividend Yield5.03%
Overview of age group and performance of ACRX stock investors
See who invests in ACRX according to age group and performance.

FAQ

How many retail Investors hold ACRX?
<0.1% of TipRanks' retail investors hold ACRX in their portfolios.
    What is ACRX Investor Sentiment?
    ACRX’s Investor Sentiment is Very Negative.
      What percentage of retail investors changed their holding of ACRX in the last 7 days?
      ▼ 9.8% of TipRanks' retail investors changed their holding of ACRX in the last 7 days.
        What percentage of retail investors changed their holding of ACRX in the last 30 days?
        ▼ 10.5% of TipRanks' retail investors changed their holding of ACRX in the last 30 days.
          What is the average age of retail investors who hold ACRX?
          The average age of ACRX Holders is between 35–55.
            What other stocks have ACRX investors also bought?
            ACRX Investors also bought MU, SNAP, AMC, SQ, MRVL, ASRT, BA, MRK, CHRS, CHPT.
              Stocks with the Most Positive Individual Investor Sentiment in the Healthcare sector
              BAXBaxter International
              BDXBecton Dickinson
              BCRXBioCryst
              BMRNBioMarin Pharmaceutical
              BIOBio-Rad Laboratories
              What's Included in PREMIUM?
              Make informed decisions based on Top Analysts' activity
              Know what industry insiders are buying
              Get actionable alerts from top Wall Street Analysts
              Find out before anyone else which stock is going to shoot up
              Get powerful stock screeners & detailed portfolio analysis